Pathogenesis of polymyalgia rheumatica
Submitted: 21 July 2017
Accepted: 18 January 2018
Published: 27 March 2018
Accepted: 18 January 2018
Abstract Views: 6160
PDF: 3871
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- G. Pasero, P. Marson, B. Gatto, A short history of anti-rheumatic therapy - VII. Biological agents , Reumatismo: Vol. 63 No. 3 (2011)
- G. Fiori, L. Amanzi, A. Moggi Pignone, F. Braschi, M. Matucci- Cerinic, The treatment of skin ulcers in patients with systemic sclerosis , Reumatismo: Vol. 56 No. 4 (2004)
- A. Alunno, G. Nocentini, O. Bistoni, R. Bianchini, E. Bartoloni Bocci, C. Riccardi, R. Gerli, Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR+CD25- cell subset in patients with systemic lupus erythematosus , Reumatismo: Vol. 62 No. 3 (2010)
- L. Andreoli, C. Nalli, M. Motta, G.L. Norman, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, T. Avcin, P.L. Meroni, A. Tincani, Subpopulations of anti-β2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β2glycoprotein I , Reumatismo: Vol. 62 No. 3 (2010)
- A. Tincani, C. Casu, S. Cartella, T. Ziglioli, R. Cattaneo, Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations , Reumatismo: Vol. 62 No. 1 (2010)
- P. Sarzi- Puttini, F. Atzeni, S. Stisi, M. Cazzola, Fibromialgia: chi deve rimodulare la percezione del dolore in questi pazienti? , Reumatismo: Vol. 60 No. s1 (2008)
- V. Bruzzese, Diffused suberitrodermic psoriasis induced by infliximab , Reumatismo: Vol. 59 No. 4 (2007)
- V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini, Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience , Reumatismo: Vol. 59 No. 3 (2007)
- A. Corrado, F.P. Cantatore, Dupuytren’s disease. State of the art and therapeutic perspectives , Reumatismo: Vol. 59 No. 2 (2007)
- E. Mainardi, A. Montanelli, Antibodies anti granulocytic antigens in IBD: from microscopic morphology to antigenic specificity , Reumatismo: Vol. 58 No. 2 (2006)
You may also start an advanced similarity search for this article.